Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. [electronic resource]
Producer: 20050428Description: 1021-32 p. digitalISSN:- 0022-3042
- Adrenergic Uptake Inhibitors -- pharmacology
- Analysis of Variance
- Animals
- Catecholamine Plasma Membrane Transport Proteins
- Cell Death -- drug effects
- Cells, Cultured
- Chlorides -- metabolism
- Dicumarol -- pharmacology
- Dopamine -- metabolism
- Dopamine Plasma Membrane Transport Proteins
- Dopamine Uptake Inhibitors
- Dose-Response Relationship, Drug
- Electron Spin Resonance Spectroscopy -- methods
- Embryo, Mammalian
- Enzyme Inhibitors -- pharmacology
- Ferric Compounds -- metabolism
- Fluorescent Antibody Technique -- methods
- Imipramine -- pharmacology
- Indolequinones -- pharmacology
- Iron -- toxicity
- Iron Isotopes -- pharmacology
- Membrane Glycoproteins -- metabolism
- Membrane Transport Modulators
- Membrane Transport Proteins -- antagonists & inhibitors
- Microscopy, Confocal -- methods
- Models, Biological
- Morpholines -- pharmacology
- Nerve Tissue Proteins -- metabolism
- Neurons -- drug effects
- Nomifensine -- pharmacology
- Norepinephrine -- pharmacology
- Norepinephrine Plasma Membrane Transport Proteins
- Rats
- Rats, Inbred F344
- Rats, Wistar
- Reboxetine
- Serotonin Plasma Membrane Transport Proteins
- Sodium -- metabolism
- Substantia Nigra -- cytology
- Symporters -- metabolism
- Thiobarbituric Acid Reactive Substances -- metabolism
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.